AAAAAA

   
Results: 1-9 |
Results: 9
Phase I-II vinorelbine (Navelbine((R))) by continuous infusion in patientswith metastatic breast cancer: Cumulative toxicities limit dose escalation
Authors: Ibrahim, NK Valero, V Rahman, Z Theriault, RL Walters, RS Buzdar, AU Booser, DJ Holmes, FA Murray, DJ Willey, J Bast, R Hortobagyi, GN
Citation: Nk. Ibrahim et al., Phase I-II vinorelbine (Navelbine((R))) by continuous infusion in patientswith metastatic breast cancer: Cumulative toxicities limit dose escalation, CANCER INV, 19(5), 2001, pp. 459-466
Long-term results of combined-modality therapy for locally advanced breastcancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience
Authors: Brito, RA Valero, V Buzdar, AU Booser, DJ Ames, F Strom, E Ross, M Theriault, RL Frye, D Kau, SW Asmar, L McNeese, M Singletary, SE Hortobagyi, GN
Citation: Ra. Brito et al., Long-term results of combined-modality therapy for locally advanced breastcancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience, J CL ONCOL, 19(3), 2001, pp. 628-633
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma
Authors: Hortobagyi, GN Buzdar, AU Theriault, RL Valero, V Frye, D Booser, DJ Holmes, FA Giralt, S Khouri, I Andersson, B Gajewski, JL Rondon, G Smith, TL Singletary, SE Ames, FC Sneige, N Strom, EA McNeese, MD Deisseroth, AB Champlin, RE
Citation: Gn. Hortobagyi et al., Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma, J NAT CANC, 92(3), 2000, pp. 225-233
Phase I study of liposomal annamycin
Authors: Booser, DJ Perez-Soler, R Cossum, P Esparza-Guerra, L Wu, QP Zou, YY Priebe, W Hortobagyi, GN
Citation: Dj. Booser et al., Phase I study of liposomal annamycin, CANC CHEMOT, 46(5), 2000, pp. 427-432
Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer
Authors: Ibrahim, NK Valero, V Theriault, RL Willey, J Walters, RS Buzdar, AU Booser, DJ Hortobagyi, GN
Citation: Nk. Ibrahim et al., Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer, AM J CL ONC, 23(2), 2000, pp. 117-121
Continuous-infusion high-dose leucovorin with 5-fluorouracil and cisplatinfor relapsed metastatic breast cancer: A phase II study
Authors: Booser, DJ Walters, RS Holmes, FA Hortobagyi, GN
Citation: Dj. Booser et al., Continuous-infusion high-dose leucovorin with 5-fluorouracil and cisplatinfor relapsed metastatic breast cancer: A phase II study, AM J CL ONC, 23(1), 2000, pp. 40-41
Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results
Authors: Holmes, FA Valero, V Walters, RS Theriault, RL Booser, DJ Gibbs, H Fraschini, G Buzdar, AU Willey, J Frye, D Asmar, L Hortobagyi, GN
Citation: Fa. Holmes et al., Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results, ANN ONCOL, 10(4), 1999, pp. 403-411
Management of breast cancer during pregnancy using a standardized protocol
Authors: Berry, DL Theriault, RL Holmes, FA Parisi, VM Booser, DJ Singletary, SE Buzdar, AU Hortobagyi, GN
Citation: Dl. Berry et al., Management of breast cancer during pregnancy using a standardized protocol, J CL ONCOL, 17(3), 1999, pp. 855-861
Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer
Authors: Buzdar, AU Singletary, SE Theriault, RL Booser, DJ Valero, V Ibrahim, N Smith, TL Asmar, L Frye, D Manuel, N Kau, SW McNeese, M Strom, E Hunt, K Ames, F Hortobagyi, GN
Citation: Au. Buzdar et al., Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer, J CL ONCOL, 17(11), 1999, pp. 3412-3417
Risultati: 1-9 |